Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 2:13:1020505.
doi: 10.3389/fpsyt.2022.1020505. eCollection 2022.

Lower-dose psycholytic therapy - A neglected approach

Affiliations
Review

Lower-dose psycholytic therapy - A neglected approach

Torsten Passie et al. Front Psychiatry. .

Abstract

Lysergic acid diethylamide (LSD) and similar psychoactive drugs have been used in psychotherapy since 1949, when the first clinical study with lower-dose LSD showed therapeutically relevant effects. This caused an intense interest among psychotherapists and researchers, alike, on an international scale. In 1960, the use of serial lower-dose LSD/psilocybin sessions in a psychoanalytical framework, which was dominant at the time, was named "psycholytic therapy". Psycholytic therapy was usually conducted in clinical environments, on both an inpatient and outpatient basis. Psycholytic therapy was developed and established over a 15-year period on the European continent, where it was used at 30 clinical treatment centers and by more than 100 outpatient psychotherapists. Psycholytic approaches were employed minimally in North America, where the psychedelic approach (use of one or two high-dose sessions for "personality-transforming mystical experiences") became the dominant method in use. The leading figure in psycholytic therapy was Professor Hanscarl Leuner in Germany, who laid the ground with his uniquely fine grained analysis of the LSD reaction in a 1962 monograph. He was central in establishing and distributing psycholytic therapy in Europe and abroad. The article provides comprehensive background information and outlines the essential features of psycholytic therapy. Evidence for the efficacy of psycholytic therapy is reviewed and a case for the inclusion of the psycholytic approach in the field of substance-assisted psychotherapy is made.

Keywords: LSD; MDMA; hallucinogens; lower-dose LSD therapy; mystical experience; psilocybin; psychoanalysis; psycholytic therapy.

PubMed Disclaimer

Conflict of interest statement

JG was an Independent Contractor with Fluence International, Inc., Woodstock, NY, United States. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Chemical structures of the main psycholytic substances lysergic acid diethylamide (LSD), psilocybin, the psilocin derivatives CEY-19, CZ-74, and the phenethylamine 2C-D.
FIGURE 2
FIGURE 2
Overview of the psycholytic therapy treatment process.
FIGURE 3
FIGURE 3
The illustration shows a treatment facility specific to psycholytic therapy as it was held in various clinics in the 1960s.
FIGURE 4
FIGURE 4
The illustration shows a treatment room with furnishings typically used in psycholytic therapy.

References

    1. Sessa B. The psychedelic renaissance. London: Muswell Hill Press; (2017). 250 p.
    1. Osmond H. A review of the clinical effects of psychotomimetic agents. Ann N Y Acad Sci. (1957) 66:418–34. 10.1111/j.1749-6632.1957.tb40738.x - DOI - PubMed
    1. Kurland A, Savage C, Pahnke WN, Grof S, Olsson JE. LSD in the treatment of alcoholics. Pharmacopsychiatry. (1971) 4:83–94. 10.1055/s-0028-1094301 - DOI
    1. Smart RG, Strom T, Baker EFW, Solursh L. Lysergic acid diethylamide in the treatment of alcoholism. An investigation of its effects on drinking behaviour, personality structure, and social functioning. Toronto: University of Toronto Press; (1967).
    1. Hollister LE, Shelton J, Krieger G. A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetamine in alcoholics. Am J Psychiatry. (1969) 125:1352–7. 10.1176/ajp.125.10.1352 - DOI - PubMed